TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
CLMT

Calumet, Inc.

Basic Materials · Specialty Chemicals

56.40$ -2.9% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Income Statement

Calumet, Inc. (CLMT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 4,137 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement CLMT
Line item 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
307 316 430 540 1,289 1,641 1,638 2,489 1,847 2,191 3,135 4,657 5,421 5,791 4,213 3,599 3,764 3,498 3,453 2,268 3,148 4,686 4,181 4,189 4,137
273 269 385 501 1,149 1,438 1,456 2,235 1,673 1,992 2,861 4,144 5,011 5,261 3,618 3,191 3,266 3,061 3,001 2,169 3,005 4,335 3,729 3,959 3,891
34 47 45 38 140 203 181 254 173 199 274 513 410 530 595 408 498 437 452 99 143 352 452 231 246
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
7.8 9.1 9.4 47 70 81 77 124 33 35 51 169 225 270 311 280 276 260 260 91 151 143 133 146 124
43 38 48 50 72 82 -82 125 106 127 149 227 318 447 486 412 369 319 375 171 229 220 185 223 192
-9.2 9.1 -2.6 -12 66 121 101 129 67 71 125 286 92 47 75 -40 158 123 76 -72 -86 132 267 8.1 54
6.2 7.4 9.5 9.9 23 9.0 4.7 34 34 30 49 86 97 111 105 162 183 156 135 126 150 176 222 237 216
-7.0 5.3 -4.9 18 11 94 83 45 62 17 44 206 3.9 -113 -168 -336 -31 -50 -43 -148 -259 -170 50 -221 -126
6.2 7.4 9.5 -21 57 0.2 0.5 0.3 0.2 0.6 0.9 0.8 0.4 -0.8 -28 -7.7 -0.1 0.7 0.5 1.1 1.5 3.4 1.6 0.8 -93
-13 5.3 -4.9 9.0 11 94 83 44 61 16 86 205 3.3 -112 -139 -329 -104 -55 -44 -149 -255 -170 48 -222 -34
-11 5.5 -2.6 -4.9 45 121 281 140 165 136 166 384 219 47 194 -40 331 236 202 83 16 104 418 165 238

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?